Presented in Partnership with Endocrine Society

Keystone Symposia and the Endocrine Society have joined forces to facilitate discovery and collaboration among basic and translational researchers, with the goal of advancing the understanding of cardiometabolism.

About This Meeting:

We are witnessing a renaissance in our understanding of the deep mechanistic interconnectedness of cardiovascular and metabolic disease, marked by a shift from siloed views of individual organs to an appreciation of dynamic interorgan communication. Exciting new science and technologies are beginning to elucidate how these complex diseases emerge from coordinated dysfunction across cardiac, metabolic, renal, skeletal muscle, hepatic, immune, and nervous systems. The therapies of tomorrow will rely on our ability to decipher this intricate crosstalk. 

This Keystone Symposia and Endocrine Society partnered conference, Cardiometabolism and Interorgan Crosstalk: Novel Mechanisms and Therapies, will convene a diverse, multidisciplinary, and international community to explore groundbreaking insights and novel therapeutic strategies. Sessions will span immune and neurological mechanisms, human genetics, AI-driven target discovery and patient segmentation, muscle-liver-heart-renal axes, obesity's systemic effects, and emerging therapies. Invited speakers will present their latest unpublished findings, with special emphasis on translation of these insights into clinical innovation. 

By fostering deep scientific engagement across attendees from a broad array of fields, this meeting will provide a unique environment for catalyzing cross-disciplinary collaboration among academia, the private sector, and public institutions. In partnership with the Endocrine Society, the conference brings together diverse professional backgrounds and perspectives essential for tackling cardiometabolic disease. 

This meeting positions itself as a unique forum for advancing integrated approaches to understanding and treating cardiometabolic disorders, providing a "bench-to-bedside-and-back" platform for discovery at a critical moment when new technologies are revealing the interconnectedness of organ systems in disease. 

Check out the speaker highlights in the video below: